’Unless an ethics committee is accredited, it should not function’
In a high level meeting held at the Apollo Group of Hospitals, Delhi, experts from various institutions, deliberated on the need…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Reversing the trend
Despite its role in maintaining health, the antibiotics market has seen considerable downturn over the last few decades. Sachin…
ABLE, WBBA sign MOU to support discoveries for better healthcare solutions
The Association of Biotechnology Led Enterprises (ABLE), and US-based Washington Biotechnology & Biomedical Association (WBBA)…
GoI to introduce innovative R&D focused pharma cluster scheme
Targeted to attract Indian R&D professionals to return & start up in India
Ranbaxy launches authorised generic of Evoxac in US healthcare market
Cevimeline hydrochloride is indicated for the treatment of symptoms of dry mouth associated with Sjogren’s syndrome
WHO prequalifies Ciplas ‘MEFLIAM Plus’ for treatment of malaria
MEFLIAM Plus, an Artesunate-Mefloquine fixed-dose combination to be rolled out throughout Asia
ABLE and WBBA sign MOU to support breakthrough discoveries for better healthcare solutions
Join hands for co-operation and investment in the field of biotechnology
Takeda and Advinus initiate multi-year drug discovery collaboration
To focus on novel targets for major therapeutic areas, including inflammation, CNS, and metabolic diseases
MSF launches Patent Opposition Database in developing countries
Database aims to boost access to medicines hit by high drug prices
Sep12 clocked decreased pharma M&A activity in both volume and value terms
MedTRACK recorded 25 M&A transactions in September 2012, against the previous six months’ average of 41.5 transactions